Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Nicholas Walter

Concepts (122)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Mycobacterium tuberculosis
18
2025
308
5.710
Why?
Tuberculosis
16
2025
272
5.130
Why?
Antitubercular Agents
12
2025
199
3.370
Why?
Tuberculosis, Pulmonary
7
2024
135
2.030
Why?
RNA, Ribosomal
2
2021
162
1.400
Why?
Sputum
7
2021
301
1.380
Why?
RNA, Bacterial
4
2025
183
1.190
Why?
Anti-Bacterial Agents
2
2025
1705
0.750
Why?
Mice, Inbred BALB C
4
2025
1227
0.680
Why?
RNA Precursors
1
2021
147
0.660
Why?
Polymerase Chain Reaction
1
2022
1027
0.620
Why?
Transcriptome
3
2025
883
0.610
Why?
Microbial Viability
1
2018
83
0.580
Why?
Diarylquinolines
3
2025
12
0.520
Why?
Disease Models, Animal
5
2025
3947
0.520
Why?
Cell Membrane
1
2018
725
0.460
Why?
Bronchoalveolar Lavage Fluid
1
2016
624
0.430
Why?
Drug Therapy, Combination
4
2025
1016
0.420
Why?
Energy Metabolism
1
2018
833
0.400
Why?
Biomarkers
3
2021
3893
0.380
Why?
Mice
6
2025
16620
0.340
Why?
Gene Expression Regulation, Bacterial
3
2023
325
0.320
Why?
Pyrazinamide
2
2025
11
0.300
Why?
Gene Expression Profiling
3
2023
1689
0.290
Why?
Linezolid
2
2025
20
0.280
Why?
Communicable Disease Control
1
2008
73
0.280
Why?
HIV Infections
6
2020
2711
0.280
Why?
Anti-Infective Agents
2
2023
245
0.250
Why?
Streptomycin
1
2025
16
0.240
Why?
Animals
6
2025
34647
0.240
Why?
Ethambutol
1
2025
25
0.240
Why?
Protein Kinases
2
2017
308
0.230
Why?
Isoniazid
1
2025
61
0.230
Why?
Tuberculosis, Multidrug-Resistant
1
2025
57
0.230
Why?
Rifampin
1
2025
85
0.230
Why?
Transcription, Genetic
2
2023
1404
0.220
Why?
Guideline Adherence
1
2008
524
0.210
Why?
Mice, Inbred C3H
1
2023
273
0.210
Why?
Mice, Inbred Strains
1
2023
402
0.200
Why?
Adaptation, Physiological
2
2023
513
0.190
Why?
Lung
3
2024
3748
0.190
Why?
Coinfection
3
2018
131
0.190
Why?
Bacterial Proteins
2
2017
833
0.170
Why?
Ethanol
1
2025
585
0.170
Why?
Female
10
2025
68266
0.170
Why?
Uganda
5
2020
72
0.170
Why?
Humans
19
2025
128495
0.150
Why?
Phenotype
2
2025
3051
0.150
Why?
Specimen Handling
2
2016
163
0.140
Why?
RNA
2
2014
881
0.140
Why?
AIDS-Related Opportunistic Infections
2
2018
123
0.130
Why?
Anti-Retroviral Agents
1
2018
231
0.130
Why?
Genes, Bacterial
1
2016
158
0.130
Why?
Drug Monitoring
1
2016
190
0.120
Why?
Microscopy
2
2013
140
0.120
Why?
Adult
7
2021
35299
0.120
Why?
Nitroimidazoles
2
2025
9
0.120
Why?
Latent Tuberculosis
1
2015
67
0.120
Why?
ROC Curve
1
2015
502
0.110
Why?
Antigens, Fungal
1
2013
27
0.110
Why?
Reagent Kits, Diagnostic
1
2013
43
0.110
Why?
Mice, Inbred C57BL
1
2023
5281
0.100
Why?
Real-Time Polymerase Chain Reaction
1
2014
324
0.100
Why?
Cryptococcosis
1
2013
25
0.100
Why?
Genome, Bacterial
1
2014
134
0.100
Why?
Nystatin
1
2012
1
0.100
Why?
Chlorhexidine
1
2012
24
0.100
Why?
DNA-Binding Proteins
2
2017
1423
0.100
Why?
Oxidative Stress
1
2018
1191
0.100
Why?
Microbial Sensitivity Tests
2
2024
352
0.100
Why?
HIV
1
2012
226
0.090
Why?
Treatment Outcome
2
2025
10162
0.090
Why?
Pneumonia
1
2015
601
0.080
Why?
RNA, Messenger
1
2016
2679
0.080
Why?
Case-Control Studies
1
2015
3339
0.070
Why?
San Francisco
1
2008
51
0.070
Why?
Emigration and Immigration
1
2008
50
0.070
Why?
Male
6
2021
63043
0.070
Why?
Inpatients
2
2020
468
0.060
Why?
United States
2
2015
13840
0.060
Why?
Oxazoles
1
2025
30
0.060
Why?
Levofloxacin
1
2025
25
0.060
Why?
Clofazimine
1
2025
15
0.060
Why?
Clinical Trials, Phase II as Topic
1
2025
72
0.060
Why?
Aged, 80 and over
1
2015
7057
0.060
Why?
Multicenter Studies as Topic
1
2025
286
0.050
Why?
Drug Administration Schedule
1
2025
764
0.050
Why?
Sensitivity and Specificity
2
2020
1817
0.050
Why?
Benchmarking
1
2023
175
0.050
Why?
Young Adult
1
2015
12349
0.040
Why?
Randomized Controlled Trials as Topic
1
2025
1358
0.040
Why?
C-Reactive Protein
1
2020
398
0.040
Why?
Middle Aged
2
2018
30921
0.040
Why?
Gambia
1
2017
14
0.030
Why?
Ghana
1
2017
34
0.030
Why?
Molecular Epidemiology
1
2017
63
0.030
Why?
Antiretroviral Therapy, Highly Active
1
2018
266
0.030
Why?
Adolescent
1
2015
20304
0.030
Why?
Aged
1
2015
21974
0.030
Why?
World Health Organization
1
2016
110
0.030
Why?
Prospective Studies
2
2020
7069
0.030
Why?
Cryptococcus
1
2013
7
0.030
Why?
Africa
1
2013
99
0.030
Why?
Standard of Care
1
2013
72
0.030
Why?
Mouthwashes
1
2012
14
0.030
Why?
HIV-1
1
2018
834
0.020
Why?
Colony Count, Microbial
1
2012
116
0.020
Why?
Diagnostic Tests, Routine
1
2013
102
0.020
Why?
Oxygen
1
2017
901
0.020
Why?
CD4 Lymphocyte Count
1
2012
267
0.020
Why?
Genotype
1
2017
1830
0.020
Why?
Survival Rate
1
2016
1871
0.020
Why?
Single-Blind Method
1
2012
268
0.020
Why?
Cough
1
2012
115
0.020
Why?
Mortality
1
2013
306
0.020
Why?
Cross-Sectional Studies
1
2020
5045
0.020
Why?
Prevalence
1
2016
2553
0.020
Why?
Polymorphism, Single Nucleotide
1
2017
2064
0.020
Why?
Practice Guidelines as Topic
1
2016
1490
0.020
Why?
Severity of Illness Index
1
2016
2719
0.020
Why?
Incidence
1
2013
2638
0.020
Why?
Time Factors
1
2012
6505
0.010
Why?
Walter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)